We are live on ! Find out more
VAM

Visium Asset Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 3.58%
This Fund
S&P 500
This Quarter Est. Return
-12.03%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.32B
AUM Growth
+$267M
Cap. Flow
+$1.37B
Cap. Flow %
18.68%
Top 10 Hldgs %
27.6%
Holding
1,433
New
327
Increased
283
Reduced
238
Closed
555

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$306M
2
CI icon
Cigna
CI
+$151M
3
PCRX icon
Pacira BioSciences
PCRX
+$143M
4
ENDP
Endo International plc
ENDP
+$120M
5
THC icon
Tenet Healthcare
THC
+$99.1M

Top Sells

Rank Stock Value
1
ESPR
Esperion Therapeutics
ESPR
+$64.7M
2
BCR
CR Bard Inc.
BCR
+$62.4M
3
PRGO icon
Perrigo
PRGO
+$52.7M
4
RCPT
RECEPTOS INC COM STK (DE)
RCPT
+$49.4M
5
SKX
Skechers
SKX
+$47.1M

Sector Composition

Rank Sector Weight
1 Healthcare 50.8%
2 Financials 7.09%
3 Consumer Discretionary 5.97%
4 Energy 5.17%
5 Industrials 4.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HBI
1001
DELISTED
Hanesbrands
HBI
– –
-100,000
Closed -$3.33M
HEI.A icon
1002
HEICO Corp Class A
HEI.A
$36B
– –
-8,859
Closed -$230K
HHH icon
1003
Howard Hughes
HHH
$3.81B
– –
-2,680
Closed -$367K
HIMX
1004
Himax Technologies
HIMX
$2.19B
– –
-64,864
Closed -$521K
HLX icon
1005
Helix Energy Solutions
HLX
$1.4B
– –
-12,598
Closed -$159K
HMY icon
1006
Harmony Gold Mining
HMY
$9.84B
– –
-41,380
Closed -$55K
HOG icon
1007
Harley-Davidson
HOG
$2.58B
– –
-8,874
Closed -$500K
HOPE icon
1008
Hope Bancorp
HOPE
$1.79B
– –
-10,808
Closed -$160K
HP icon
1009
Helmerich & Payne
HP
$3.45B
– –
-3,084
Closed -$217K
HQY icon
1010
HealthEquity
HQY
$8.41B
– –
-7,600
Closed -$244K
HSY icon
1011
Hershey
HSY
$35.5B
– –
-5,067
Closed -$450K
HUN icon
1012
Huntsman Corp
HUN
$1.71B
– –
-224,489
Closed -$4.96M
HWC icon
1013
Hancock Whitney
HWC
$6.2B
– –
-10,397
Closed -$332K
IBKR icon
1014
Interactive Brokers
IBKR
$39.2B
– –
-52,340
Closed -$544K
IBM icon
1015
IBM
IBM
$211B
– –
-2,671
Closed -$415K
ICLR icon
1016
Icon
ICLR
$12.6B
– –
-252,410
Closed -$17M
IDCC icon
1017
InterDigital
IDCC
$7.88B
– –
-8,881
Closed -$505K
IFF icon
1018
International Flavors & Fragrances
IFF
$20.2B
– –
-2,338
Closed -$256K
IMAX icon
1019
CALL
IMAX
IMAX
$2.62B
– –
-1,000
Closed -$14K
IMAX icon
1020
IMAX
IMAX
$2.62B
– –
-84,040
Closed -$3.38M
IMKTA icon
1021
Ingles Markets
IMKTA
$1.71B
– –
-5,261
Closed -$251K
IMOS
1022
ChipMOS TECHNOLOGIES
IMOS
$1.65B
– –
-59,051
Closed -$1.42M
INGN icon
1023
Inogen
INGN
$175M
– –
-15,500
Closed -$691K
INSG icon
1024
Inseego
INSG
$114M
– –
-2,101
Closed -$68K
IONS icon
1025
Ionis Pharmaceuticals
IONS
$8.6B
– –
-12,100
Closed -$696K
39 40
41
42 43

Similar funds

FBNAT
FirstMerit Bank N.A. Trustee Akron, Ohio $1.24B AUM 5.12% 1-Year Est. Return
CPS
Counsel Portfolio Services Mississauga, Ontario, Canada $1.01B AUM 2.83% 1-Year Est. Return
LH
Lebenthal Holdings New York $806M AUM 2.13% 1-Year Est. Return
CPM
Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
ZA
Zweig Advisers Hartford, Connecticut $586M AUM 1.34% 1-Year Est. Return
FVFIGP
Flagship Ventures Fund IV General Partner Cambridge, Massachusetts $585M AUM
WA
Westport Advisers Westport, Connecticut $542M AUM 2.07% 1-Year Est. Return

Visium Asset Management's Q3 2015 Portfolio in Review

As of Q3 2015, Visium Asset Management held 1,433 positions worth $7.32B, up 3.8% from $7.05B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Visium Asset Management deployed $1.37B of net new capital in Q3 2015, opening 327 new positions and adding to 283 existing holdings. Its largest new stake was Allergan plc: 997,201 shares worth $271M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 49% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Perrigo, an estimated $52.7M trimmed.

  • Visium Asset Management's largest Q3 2015 buy was Allergan plc: 997,201 shares worth $271M.
  • Visium Asset Management added most to Pacira BioSciences in Q3 2015, an estimated $143M increase.
  • Visium Asset Management's biggest Q3 2015 reduction was Perrigo, cutting an estimated $52.7M.
  • Visium Asset Management fully exited Esperion Therapeutics in Q3 2015, selling an estimated $64.7M.
  • Visium Asset Management's ten largest holdings make up 28% of its $7.32B portfolio in Q3 2015.
  • Visium Asset Management opened 327 new positions and closed 555 in Q3 2015.
  • Visium Asset Management's portfolio value rose 3.8% quarter-over-quarter to $7.32B.

Based on Visium Asset Management's 13F filing for Q3 2015, filed 16 Nov 2015.